testing
-
Devices & Diagnostics, Sponsored Post
The Covid-19 Pandemic Has Served as a Catalyst for Diagnostic Transformation
The Covid-19 pandemic has transformed the way we think of diagnostics in our daily lives. In a recent webinar, BD Vice President for Diagnostics Nikos Pavlidis spoke with a clinician and an epidemiologist where they shared their perspectives on how testing developments have changed the way we track respiratory illnesses.
-
Diagnostic startups: Time is running out to apply to INVEST Pitch Perfect
The point of care diagnostics and testing market has climbed dramatically with the rise of the Covid-19 public health crisis. We’re seeking applications for diagnostics startups who would like to take part in INVEST Pitch Perfect Diagnostics 2.0 track at the conference, scheduled to take place March 28-30 in Chicago.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Healthcare leaders: disorganization, disparities characterized health crisis
Reflecting on lessons learned from the pandemic, healthcare leaders pointed to the lack of coordination and glaring health disparities that hampered the U.S. pandemic response. Going forward, they hope to see future change in the healthcare system.
-
Demand for at-home testing propels Everlywell to $175M in new funding
The Austin-based startup has distributed more than 500,000 Covid-19 test kits to date, and expects total sales to quadruple by the end of the year.
-
Four takeaways from CVS Health’s Q3 earnings
CVS Health named a new CEO in its earnings call on Friday. Between plans to further integrate its pharmacy and insurance businesses, and discussion about how a Covid-19 vaccine would be distributed, here are four other things the company is preparing for in the coming months.
-
CVS to roll out rapid Covid-19 testing at 1,000 sites
CVS Health plans to add rapid Covid-19 tests at 1,000 locations by the end of the year. The company has not specified which rapid tests it will offer.
-
CMS to pay less for Covid-19 test results that take longer than two days
Starting in January, Medicare will pay $75 for tests that take longer than two days to deliver results. It currently pays $100 for each high-throughput Covid-19 test.
-
Lessons learned from Verily’s Covid-19 testing efforts
Google’s sister company launched a program in California and other states to help route patients to nearby coronavirus testing. Dr. Vivian Lee, president of health platforms for Verily, shared lessons learned from that effort and Verily’s work with schools and businesses.
-
Retail Health, Startups, Diagnostics
Sean Slovenski shares why he joined a testing startup, and what’s next for Walmart Health
Slovenski, who helped create the idea for Walmart’s health centers, left the company in August to join testing startup BioIQ. He shares how he built Walmart’s new health strategy from the ground up and what’s next at his new role.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
After FDA authorizes at-home saliva test for Covid-19, startups begin selling test kits
The FDA gave an emergency use authorization for the first saliva-based Covid-19 test developed by RUCDR Infinite Biologics. Now, startups are once again trying their hand at selling test kits.
-
Do-it-yourself cheek swab tested as next best thing to detect coronavirus
At 21 drive-thru sites, anyone can now provide a sample by swishing a cotton swab around their mouths, putting it in a tube and dropping it in a receptacle on their way out — all within the comfort of their cars.
-
Retail execs promise to ramp up Covid-19 testing
The two pharmacy chains plan to ramp up testing locations, with CVS saying it will add 1,000 sites and Walgreens saying it will add drive-thru testing in all 49 states. Currently, they have just a handful of sites across the U.S.
-
Physician surveys show widespread concern about access to testing, medical supplies
Two surveys released on Thursday showed many physicians don’t feel like they have adequate access to testing and medical supplies. A survey of more than 2,600 U.S. physicians showed the vast majority — 73 percent — said they were not able to test patients quickly and easily.
-
FDA warns against at-home Covid-19 tests
The Food and Drug Administration updated its guidance to note that it has not approved any at-home tests for Covid-19. A number of startups began offering private tests, for a cost, after a public shortage of testing has left many with symptoms searching for solutions.
-
Google: COVID-19 triage website is in early stages of development
After declaring a state of emergency on Friday, Trump announced that Google would be building a website that could route users to drive-thru testing sites for COVID-19. Alphabet’s subsidiary, Verily, said the tool was in the early stages of development, and that it planned to roll out testing in the Bay Area.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
